1. Home
  2. APT vs INKT Comparison

APT vs INKT Comparison

Compare APT & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha Pro Tech Ltd.

APT

Alpha Pro Tech Ltd.

HOLD

Current Price

$5.58

Market Cap

59.6M

Sector

N/A

ML Signal

HOLD

Logo MiNK Therapeutics Inc.

INKT

MiNK Therapeutics Inc.

HOLD

Current Price

$11.22

Market Cap

59.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APT
INKT
Founded
1983
2017
Country
Canada
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
59.6M
59.4M
IPO Year
1997
2021

Fundamental Metrics

Financial Performance
Metric
APT
INKT
Price
$5.58
$11.22
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $39.00
AVG Volume (30 Days)
★ 69.5K
16.2K
Earning Date
11-04-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.24
N/A
Revenue
★ $59,142,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$17.65
P/E Ratio
$23.04
★ N/A
Revenue Growth
★ 2.25
N/A
52 Week Low
$4.34
$8.48
52 Week High
$7.50
$15.27

Technical Indicators

Market Signals
Indicator
APT
INKT
Relative Strength Index (RSI) 54.54 49.68
Support Level $5.46 $10.85
Resistance Level $5.77 $12.38
Average True Range (ATR) 0.24 0.65
MACD -0.02 -0.03
Stochastic Oscillator 28.08 57.14

Price Performance

Historical Comparison
APT
INKT

About APT Alpha Pro Tech Ltd.

Alpha Pro Tech Ltd is in the business of protecting people, products, and environments. It is developing, manufacturing, and marketing a line of disposable protective apparel and infection control products for the cleanroom, industrial, pharmaceutical, medical, and dental markets. It also manufactures a line of building supply construction weatherization products that are sold under the Alpha Pro Tech brand name. The Company operates through two business segments: Building Supply and Disposable Protective Apparel. Key revenue is generated from Building Supply, consisting of a line of construction supply weatherization products. The construction supply weatherization products consist of housewrap and synthetic roof underlayment, and synthetic roof underlayment accessories.

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development and manufacturing of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. iNKT cells offer distinct therapeutic advantages as a platform for allogeneic therapy in that the cells naturally home to tissues, aid clearance of tumors and infected cells, and suppress graft-versus-host-disease. Its product candidate, agenT-797, is an off-the-shelf, allogeneic, native iNKT cell therapy. It operates its business in single segment.

Share on Social Networks: